INTERNATIONAL PATENT: SWISS ROCKETS AG FILES APPLICATION FOR "COMBINATION THERAPY USING PSMA-TARGETED RADIOPHARMACEUTICALS AND AN INHIBITOR OF PI3K, AKT AND/OR MTOR"

GENEVA, June 23 -- SWISS ROCKETS AG (Lautengartenstrasse 64052 Basel) filed a patent application (PCT/EP2024/085997) for "COMBINATION THERAPY USING PSMA-TARGETED RADIOPHARMACEUTICALS AND AN INHIBITOR OF PI3K, AKT, AND/OR MTOR" on Dec 12, 2024. With publication no. WO/2025/125469, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CMILJANOVIC, Vladimir (Fullinsdorferstrasse 9c4304 Giebenach), GRACHEVA, Nadezda (Fullinsdorferstrasse 9c4304 Giebenach)

Abstract: The disclosure relates to kits of parts and compositions compris...